使用光谱成形技术的全身超低剂量CT检测多发性骨髓瘤溶骨性病变
回顾性纳入30例多发性骨髓瘤患者,比较第三代双源CT锡滤过100 kV协议与第二代双源CT标准低剂量协议的全身低剂量CT,评估辐射剂量与图像质量。锡滤过组主观整体图像质量显著更高,溶骨性病变检出频率无显著差异,中位有效剂量显著更低(1.45 mSv vs 5.65 mSv),降低约74%。
要点
- 锡滤过100 kV全身低剂量CT中位有效剂量1.45 mSv,较标准低剂量协议5.65 mSv降低约74%。
- 两组溶骨性病变检出频率无显著差异(p=0.259),所有扫描均达诊断图像质量。
- 锡滤过组主观整体图像质量显著更高(p=0.0003),但骨结构客观信号强度及信噪比等对照组相等或显著更高。
核心结论
- 采用Sn 100 kV的全身低剂量CT可获得足以显示溶骨性病变的图像质量,同时辐射剂量降低约74%。
研究设计与样本
- 回顾性研究,连续选取30例在多发性骨髓瘤患者,使用第三代双源CT行全身低剂量CT(Sn 100 kV,参考mAs 130),并与第二代双源CT标准低剂量协议(100 kV,参考mAs 111)匹配患者比较。
诊断标准与关键数值
- 中位有效剂量:研究组1.45 mSv vs 对照组5.65 mSv(p<0.0001),研究方案降低约74%。
- 主观整体图像质量研究组显著高于对照组(p=0.0003)。
- 骨结构客观信号强度、信噪比和对比噪声比对照组相等或显著更高。
- 溶骨性病变检出频率两组无显著差异(p=0.259)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The aim of this study was to investigate the radiation dose and image quality of a whole-body low-dose CT (WBLDCT) using spectral shaping at 100 kV (Sn 100 kV) for the assessment of osteolytic lesions in patients with multiple myeloma.
METHODS: Thirty consecutive patients were retrospectively selected, who underwent a WBLDCT on a third-generation dual-source CT (DSCT) (Sn 100 kV, ref. mAs: 130). They were matched with patients, who were examined on a second-generation DSCT with a standard low-dose protocol (100 kV, ref. mAs: 111). Objective and subjective image quality, radiation exposure as well as the frequency of osteolytic lesions were evaluated.
RESULTS: All scans were of diagnostic image quality. Subjective overall image quality was significantly higher in the study group (p = 0.0003). Objective image analysis revealed that signal intensities, signal-to-noise ratio and contrast-to-noise ratio of the bony structures were equal or significantly higher in the control group. There was no significant difference in the frequency of osteolytic lesions (p = 0.259). The median effective dose of the study protocol was significantly lower (1.45 mSv vs. 5.65 mSv; p < 0.0001).
CONCLUSION: WBLDCT with Sn 100 kV can obtain sufficient image quality for the depiction of osteolytic lesions while reducing the radiation dose by approximately 74%.
KEY POINTS: • Spectral shaping using tin filtration is beneficial for whole-body low-dose CT • Sn 100 kV yields sufficient image quality for depiction of osteolytic lesions • Whole-body low-dose CT can be performed with a median dose of 1.5 mSv.
引用
- Suntharalingam S, Mikat C, Wetter A, et al. Whole-body ultra-low dose CT using spectral shaping for detection of osteolytic lesion in multiple myeloma. Eur Radiol. 2018. PMID: 29322333. doi:10.1007/s00330-017-5243-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。